Clinical Trials Directory

Trials / Conditions / Stage IVA Uterine Corpus Cancer AJCC v8

Stage IVA Uterine Corpus Cancer AJCC v8

9 registered clinical trials studyying Stage IVA Uterine Corpus Cancer AJCC v8 — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa
NCT05092373
M.D. Anderson Cancer CenterPhase 1
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
M.D. Anderson Cancer CenterPhase 1
CompletedSexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gyn
NCT04269837
Ohio State University Comprehensive Cancer CenterN/A
WithdrawnAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
NCT04498520
Pamela MunsterPhase 1
RecruitingPIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorecta
NCT04329494
City of Hope Medical CenterPhase 1
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
RecruitingTalazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT03968406
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingA Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Re
NCT03008408
M.D. Anderson Cancer CenterPhase 2